GlassScriptPhysician profile
Nicholas P Grosso
NPI 1376547125
$1,410.13
in general payments reported to CMS, 2019-2025
10 companies · $782 in 2025
The $782 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $38.90 · 2021: $272 · 2022: $40.18 · 2025: $782.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $782.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $782.00 | 2025 | |
| Stryker Corporation | $194.10 | 2019-2021 | |
| Smith+Nephew, INC. | $149.56 | 2021 | |
| Biocomposites INC | $95.86 | 2019 | |
| Zimmer Biomet Holdings, INC. | $46.62 | 2019 | |
| Depuy Synthes Sales INC. | $40.18 | 2022 | |
| Bioventus LLC | $38.90 | 2020 | |
| 4web, INC. | $29.19 | 2021 | |
| Sanofi-Aventis U.S. LLC | $19.69 | 2019 | |
| Heraeus Medical, LLC. | $14.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Grosso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.